Literature DB >> 34232602

Morphologic and Molecular Findings in Myxoid Hepatic Adenomas.

Daniel J Rowan1, Saba Yasir1, Zongming E Chen1, Taofic Mounajjed1, Sibel Erdogan Damgard1, Lisa Cummins1, Lizhi Zhang1, Emma Whitcomb2, Vince Falck2, Sanford M Simon3, Aatur D Singhi4, Michael S Torbenson1.   

Abstract

Myxoid hepatic adenomas are a rare subtype of hepatic adenomas with distinctive deposition of extracellular myxoid material between the hepatic plates. A total of 9 cases were identified in 6 women and 3 men with an average of 59±12 years. The myxoid adenomas were single tumors in 5 cases and multiple in 4 cases. In 1 case with multiple adenomas, the myxoid adenoma arose in the background of GNAS-mutated hepatic adenomatosis. Myxoid hepatic adenomas had a high frequency of malignant transformation (N=5 cases). They were characterized at the molecular level by HNF1A inactivating mutations, leading to loss of LFABP protein expression. In addition, myxoid adenomas had recurrent mutations in genes within the protein kinase A (PKA) pathway or in genes that regulate the PKA pathway: GNAS, CDKN1B (encodes p27), and RNF123. In sum, myxoid adenomas are rare, occur in older-aged persons, have a high risk of malignant transformation, and are characterized by the combined inactivation of HNF1A and additional mutations that appear to cluster in the PKA pathway.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34232602      PMCID: PMC8608350          DOI: 10.1097/PAS.0000000000001711

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.298


  30 in total

1.  Transcriptomic characterization of fibrolamellar hepatocellular carcinoma.

Authors:  Elana P Simon; Catherine A Freije; Benjamin A Farber; Gadi Lalazar; David G Darcy; Joshua N Honeyman; Rachel Chiaroni-Clarke; Brian D Dill; Henrik Molina; Umesh K Bhanot; Michael P La Quaglia; Brad R Rosenberg; Sanford M Simon
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-21       Impact factor: 11.205

2.  Malignant transformation of liver fatty acid binding protein-deficient hepatocellular adenomas: histopathologic spectrum of a rare phenomenon.

Authors:  Juan Putra; Linda D Ferrell; Annette S H Gouw; Valerie Paradis; Arvind Rishi; Christine Sempoux; Charles Balabaud; Swan N Thung; Paulette Bioulac-Sage
Journal:  Mod Pathol       Date:  2019-09-30       Impact factor: 7.842

3.  Fibrolamellar carcinoma in the Carney complex: PRKAR1A loss instead of the classic DNAJB1-PRKACA fusion.

Authors:  Rondell P Graham; Carolin Lackner; Luigi Terracciano; Yessica González-Cantú; Joseph J Maleszewski; Patricia T Greipp; Sanford M Simon; Michael S Torbenson
Journal:  Hepatology       Date:  2018-05-11       Impact factor: 17.425

4.  Chromosomal abnormalities determined by comparative genomic hybridization are helpful in the diagnosis of atypical hepatocellular neoplasms.

Authors:  Sanjay Kakar; Xin Chen; Coral Ho; Lawrence J Burgart; Oyedele Adeyi; Dhanpat Jain; Viabhav Sahai; Linda D Ferrell
Journal:  Histopathology       Date:  2009-08       Impact factor: 5.087

5.  Fibrolamellar hepatocellular carcinoma occurring 5 years after hepatocellular adenoma in a 14-year-old girl: a case report with comparative genomic hybridization analysis.

Authors:  Luigi Maria Terracciano; Luigi Tornillo; Pierino Avoledo; Dietrich Von Schweinitz; Thomas Kühne; Elisabeth Bruder
Journal:  Arch Pathol Lab Med       Date:  2004-02       Impact factor: 5.534

6.  Myxoid hepatocellular neoplasms: imaging appearance of a unique mucinous tumor variant.

Authors:  Jesse T Young; Anil N Kurup; Rondell P Graham; Michael S Torbenson; Sudhakar K Venkatesh
Journal:  Abdom Radiol (NY)       Date:  2016-11

Review 7.  Molecular genetics of the cAMP-dependent protein kinase pathway and of sporadic pituitary tumorigenesis.

Authors:  Sosipatros A Boikos; Constantine A Stratakis
Journal:  Hum Mol Genet       Date:  2007-04-15       Impact factor: 6.150

8.  Epigenetic silencing of HNF1A associates with changes in the composition of the human plasma N-glycome.

Authors:  Vlatka Zoldoš; Tomislav Horvat; Mislav Novokmet; Cyrille Cuenin; Ana Mužinić; Maja Pučić; Jennifer E Huffman; Olga Gornik; Ozren Polašek; Harry Campbell; Caroline Hayward; Alan F Wright; Igor Rudan; Katharine Owen; Mark I McCarthy; Zdenko Herceg; Gordan Lauc
Journal:  Epigenetics       Date:  2012-02       Impact factor: 4.528

9.  Immunostains Used to Subtype Hepatic Adenomas Do Not Distinguish Hepatic Adenomas From Hepatocellular Carcinomas.

Authors:  Liping Liu; Sejal S Shah; Bita V Naini; Samuel French; Tsung-Teh Wu; Michael S Torbenson; Vishal S Chandan
Journal:  Am J Surg Pathol       Date:  2016-08       Impact factor: 6.394

Review 10.  Myxoid hepatocellular adenoma, a rare variant of hepatocellular adenoma with distinct imaging features: A case report with immunohistochemical and molecular analysis and literature review.

Authors:  Nicolas De Vos; Joni Van der Meulen; Malaïka Van Der Linden; Kathleen Claes; Ann-Sophie Candaele; Aude Vanlander; Roberto Ivan Troisi; Hans Van Vlierberghe; Peter Smeets; Jo Van Dorpe; Anne Hoorens
Journal:  Clin Res Hepatol Gastroenterol       Date:  2020-06-30       Impact factor: 2.947

View more
  2 in total

1.  Hepatic Adenomas in Patients 60 and Older Are Enriched for HNF1A Inactivation and Malignant Transformation.

Authors:  Saba Yasir; Zongming E Chen; Dhanpat Jain; Sanjay Kakar; Tsung-Teh Wu; Matthew M Yeh; Michael S Torbenson
Journal:  Am J Surg Pathol       Date:  2022-04-06       Impact factor: 6.298

2.  Hepatocellular adenoma: Where are we now?

Authors:  Xi Wang; Xuchen Zhang
Journal:  World J Gastroenterol       Date:  2022-04-14       Impact factor: 5.374

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.